Sleep apnea is emerging as a significant public health concern, with new data suggesting that millions may be living with undiagnosed conditions that could impact long-term health.
New research indicates that mild sleep apnea may be far more widespread than previously understood — and its health risks may be underestimated.
A large-scale analysis of sleep data has found that around one in five people in the UK may experience signs of mild sleep apnea, a condition that disrupts breathing during sleep and is increasingly linked to serious health outcomes.
The study, based on more than two million nights of anonymised sleep data, also points to a broader trend: sleep quality is gradually declining, with people sleeping less on average year over year.
Sleep Apnea Is More Than a Sleep Issue
Sleep apnea occurs when breathing repeatedly stops and starts during sleep, often without the individual being aware. While commonly associated with fatigue and poor sleep quality, its long-term implications are far more serious.
A growing body of research shows that sleep apnea is closely linked to cardiovascular and metabolic conditions, including increased risk of hypertension, atrial fibrillation, and Type 2 diabetes.
Recent findings published in Nature Digital Medicine further reinforce this concern. The study — which you can explore in this new scientific research on sleep apnea variability and cardiovascular risk highlights that it is not just the severity of sleep apnea that matters, but also how much breathing patterns fluctuate from night to night.
This variability may place individuals with so-called “mild” sleep apnea at a level of cardiovascular risk previously associated only with more severe cases.
A Widespread and Underdiagnosed Condition
Globally, sleep apnea is estimated to affect around one billion people, making it one of the most common yet underdiagnosed health conditions.
The latest data suggests that prevalence increases significantly with age, particularly after 50, and that men are more likely to experience the condition than women — although risk rises for women after menopause.
Despite its prevalence, sleep apnea often goes undetected because symptoms can be subtle or mistaken for general fatigue, stress, or lifestyle-related sleep disruption.
Sleep Quality Is Gradually Declining
Beyond sleep apnea itself, the data reveals a broader deterioration in sleep health.
Average sleep duration has decreased year-on-year, accompanied by a slight drop in overall sleep quality scores. Seasonal variations also play a role, with shorter sleep durations typically recorded during summer months.
These patterns suggest that modern lifestyles — including stress, screen exposure, and irregular schedules — may be contributing to worsening sleep outcomes at a population level.
The Role of Connected Health Monitoring
The findings also highlight the growing role of connected health technologies in identifying sleep disorders earlier and tracking long-term trends.
Platforms such as Withings are part of a wider shift toward continuous, at-home health monitoring, where users can collect longitudinal data on sleep patterns, heart rate, and other key indicators.
While these tools are not a substitute for clinical diagnosis, they are increasingly being used to support preventative healthcare — helping both individuals and clinicians detect patterns that might otherwise go unnoticed.
Conclusion
Sleep apnea is no longer a niche or isolated condition — it is increasingly recognised as a widespread health issue with significant implications for long-term wellbeing.
As research continues to highlight the connection between sleep and cardiovascular health, and as sleep quality trends decline globally, the importance of early detection and ongoing monitoring will only grow.
In this context, sleep health is becoming a critical pillar of preventative healthcare — and one that is likely to shape both medical research and consumer health technology in the years ahead.